Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Chantez Bailey at [email protected].

  • February 20, 2025

    UsAgainstAlzheimer’s Calls on Congress to Protect and Continue Investment in Alzheimer’s Research and Treatment

    Read more
  • February 14, 2025

    Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure

    Read more
  • January 27, 2025

    UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi® Monthly Dosing

    UsAgainstAlzheimer’s chair and co-founder George Vradenburg issued the following statement in response...

    Read more
  • December 12, 2024

    BOLD Act Signed into Law to Strengthen Alzheimer’s Research and Support

    UsAgainstAlzheimer’s applauds the signing of the Building Our Largest Dementia (BOLD) Infrastructure...

    Read more
  • November 22, 2024

    Senate Passes BOLD Act to Strengthen Alzheimer's Public Health Response

    UsAgainstAlzheimer’s chair and co-founder, George Vradenburg, issued the following statement in response...

    Read more
  • November 14, 2024

    UsAgainstAlzheimer’s Statement on Alzheimer’s Treatment Approval in the European Union

    UsAgainstAlzheimer’s applauds the Committee for Medicinal Products for Human Use (CHMP) of...

    Read more
  • October 23, 2024

    Members of Congress Call for More Action on Alzheimer’s

    Read more
  • October 10, 2024

    New Poll: Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-approved Early Alzheimer’s Medications the Same Way They Do for All Other Diseases

    American voters are willing to pay more to ensure access and want...

    Read more
  • October 02, 2024

    President Signs NAPA Reauthorization and AAIA into Law—A Major Victory in the Fight Against Alzheimer’s

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.

Read Report